COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
The Food and Drug Administration said it is adopting more stringent standards for COVID-19 antibody tests.
The Food and Drug Administration issued Gilead Sciences an emergency use authorization for the investigational antiviral drug remdesivir to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease.
The Food and Drug Administration issued Gilead Sciences an emergency use authorization for the investigational antiviral drug remdesivir to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease.
The Food and Drug Administration issued Gilead Sciences an emergency use authorization for the investigational antiviral drug remdesivir to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease.
An independent commission will assess the response to COVID-19 and offer recommendations to nursing homes, the Centers for Medicare & Medicaid Services announced.
The Food and Drug Administration yesterday approved for emergency use a ventilator specially developed by the National Aeronautics and Space Administration to treat COVID-19 patients.
The Centers for Medicare & Medicaid Services released a number of new waivers related to COVID-19. The waivers apply nationwide and are generally retroactive to March 1, 2020.
The Centers for Medicare & Medicaid Services (CMS) yesterday released a number of new waivers related to COVID-19.
Statement on additional regulatory waivers from CMS from AHA President and CEO Rick Pollack.
The Food and Drug Administration issued an emergency use authorization for Abbott Laboratory’s SARS-CoV-2 IgG assay for the qualitative detection of COVID-19 antibodies.